108 related articles for article (PubMed ID: 36497230)
1. Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma.
Diepstraten FA; Wiersma J; Schoot RA; Knops RRG; Zuur CL; Meijer AJM; Dávila Fajardo R; Pieters BR; Balgobind BV; Westerveld H; Freling N; van Tinteren H; Smeele LE; Bel A; van den Heuvel-Eibrink MM; Stokroos RJ; Merks JHM; Hoetink AE; Hol MLF
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497230
[TBL] [Abstract][Full Text] [Related]
2. Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.
Schoot RA; Theunissen EA; Slater O; Lopez-Yurda M; Zuur CL; Gaze MN; Chang YC; Mandeville HC; Gains JE; Rajput K; Pieters BR; Davila Fajardo R; Talwar R; Caron HN; Balm AJ; Dreschler WA; Merks JH
Clin Otolaryngol; 2016 Jun; 41(3):276-83. PubMed ID: 26293165
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
Clemens E; Brooks B; de Vries ACH; van Grotel M; van den Heuvel-Eibrink MM; Carleton B
PLoS One; 2019; 14(2):e0210646. PubMed ID: 30763334
[TBL] [Abstract][Full Text] [Related]
4. Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
Murphy B; Jackson A; Bass JK; Tsang DS; Ronckers CM; Kremer L; Baliga S; Olch A; Zureick AH; Jee KW; Constine LS; Yock TI
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):446-456. PubMed ID: 37855793
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
6. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment.
Schoot RA; Slater O; Ronckers CM; Zwinderman AH; Balm AJ; Hartley B; van den Brekel MW; Gupta S; Saeed P; Gajdosova E; Pieters BR; Gaze MN; Mandeville HC; Fajardo RD; Chang YC; Gains JE; Strackee SD; Dunaway D; Abela C; Mason C; Smeele LE; Chisholm JC; Levitt GA; Kremer LC; Grootenhuis MA; Maurice-Stam H; Stiller CA; Hammond P; Caron HN; Merks JH
Eur J Cancer; 2015 Jul; 51(11):1424-34. PubMed ID: 25998323
[TBL] [Abstract][Full Text] [Related]
7. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.
Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1488-1495. PubMed ID: 33677052
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
Vaarwerk B; Schoot RA; Maurice-Stam H; Slater O; Hartley B; Saeed P; Gajdosova E; van den Brekel MW; Balm AJM; Hol MLF; van Jaarsveld S; Kremer LCM; Ronckers CM; Mandeville HC; Pieters BR; Gaze MN; Davila Fajardo R; Strackee SD; Dunaway D; Smeele LE; Chisholm JC; Caron HN; Grootenhuis MA; Merks JHM
Pediatr Blood Cancer; 2019 Feb; 66(2):e27498. PubMed ID: 30318743
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial module.
Morfouace M; Hol MLF; Schoot RA; Slater O; Indelicato DJ; Kolb F; Smeele LE; Merks JHM; Rae C; Maurice-Stam H; Klassen AF; Grootenhuis MA
Cancer Med; 2023 Feb; 12(4):4739-4750. PubMed ID: 36208014
[TBL] [Abstract][Full Text] [Related]
10. Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children.
Keilty D; Khandwala M; Liu ZA; Papaioannou V; Bouffet E; Hodgson D; Yee R; Cushing S; Laperriere N; Ahmed S; Mabbott D; Ramaswamy V; Tabori U; Huang A; Bartels U; Tsang DS
J Clin Oncol; 2021 Dec; 39(34):3813-3821. PubMed ID: 34570616
[TBL] [Abstract][Full Text] [Related]
11. [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].
Schmidt CM; Bartholomäus E; Deuster D; Heinecke A; Dinnesen AG
HNO; 2007 Apr; 55(4):299-306. PubMed ID: 16437215
[TBL] [Abstract][Full Text] [Related]
12. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.
Hua C; Bass JK; Khan R; Kun LE; Merchant TE
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):892-9. PubMed ID: 18395355
[TBL] [Abstract][Full Text] [Related]
13. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
[TBL] [Abstract][Full Text] [Related]
14. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
Bass JK; Huang J; Onar-Thomas A; Chang KW; Bhagat SP; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Heath JA; McCowage G; Cohn RJ; Fisher MJ; Robinson G; Broniscer A; Gajjar A; Gurney JG
Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
[TBL] [Abstract][Full Text] [Related]
15. Facial asymmetry in head and neck rhabdomyosarcoma survivors.
Schoot RA; Hol MLF; Merks JHM; Suttie M; Slater O; van Lennep M; Hopman SMJ; Dunaway D; Syme-Grant J; Smeele LE; Zwinderman KH; Caron HN; Hammond P
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28423221
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up.
Skalleberg J; Småstuen MC; Oldenburg J; Osnes T; Fosså SD; Bunne M
Laryngoscope; 2020 Sep; 130(9):E515-E521. PubMed ID: 32065408
[TBL] [Abstract][Full Text] [Related]
17. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity?
Schultz C; Pecora Liberman PH; Schmidt Goffi-Gomez MV
Audiol Neurootol; 2019; 24(5):253-257. PubMed ID: 31661686
[TBL] [Abstract][Full Text] [Related]
18. Hearing Loss in Adult Survivors of Childhood Cancer Treated with Radiotherapy.
Khan A; Budnick A; Barnea D; Feldman DR; Oeffinger KC; Tonorezos ES
Children (Basel); 2018 May; 5(5):. PubMed ID: 29734694
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.
Feder KP; Michaud D; McNamee J; Fitzpatrick E; Ramage-Morin P; Beauregard Y
Ear Hear; 2017; 38(1):7-20. PubMed ID: 27556530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
